Budepress 200mcg Inhaler (Formoterol Fumarate 6.0 Mcg+Budesonide 200.0 Mcg)

Composition:
Each metered dose contains:

Formoterol Fumarate Dihydrate IP 6.0 mcg,Budesonide IP 200.0 mcg

Propellant & Excipients: q.s.

Description:
Budepress 200 Inhaler is a combination inhalation therapy containing Budesonide, a corticosteroid, and Formoterol Fumarate, a long-acting β₂-adrenergic agonist (LABA).

The combination provides both anti-inflammatory and bronchodilatory effects for effective control of asthma and chronic obstructive pulmonary disease (COPD).

Warnings and Precautions:

For inhalation use only; not for relief of acute bronchospasm.

Rinse mouth after each use to reduce risk of oral candidiasis.

Use with caution in patients with cardiovascular disorders, thyrotoxicosis, or hypokalemia.

Regular monitoring of lung function and symptom control is advised.

Avoid abrupt discontinuation of corticosteroids.

Contraindicated in patients with hypersensitivity to any component of the inhaler.

Adverse Effects:

Common: Throat irritation, hoarseness, cough, headache, tremor.

Occasional: Oral candidiasis, palpitations, muscle cramps.

Rare: Hypokalemia, paradoxical bronchospasm, systemic corticosteroid effects on prolonged use.

Storage:

Store below 30°C, protected from heat, direct sunlight, and moisture.

Do not puncture or incinerate even when empty.

Keep out of reach of children.